Skip to main content
logo
Laurus Labs Limited (NSE:LAURUSLABS)
India flag India · Delayed Price · Currency is INR
849.35
-25.00 (-2.86%)
Aug 1, 2025, 3:30 PM IST

Theseus Pharmaceuticals Revenue

Laurus Labs had revenue of 15.70B INR in the quarter ending June 30, 2025, with 31.35% growth. This brings the company's revenue in the last twelve months to 59.29B, up 17.31% year-over-year. In the fiscal year ending March 31, 2025, Laurus Labs had annual revenue of 55.54B with 10.18% growth.

Revenue (ttm)
59.29B
Revenue Growth
+17.31%
P/S Ratio
7.73
Revenue / Employee
9.61M
Employees
6,167
Market Cap
458.50B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202555.54B5.13B10.18%
Mar 31, 202450.41B-10.00B-16.55%
Mar 31, 202360.41B11.05B22.39%
Mar 31, 202249.36B1.22B2.54%
Mar 31, 202148.14B19.82B69.99%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries525.78B
Divi's Laboratories93.60B
Cipla274.80B
Apollo Hospitals Enterprise217.94B
Mankind Pharma122.07B
Zydus Lifesciences232.42B
Aurobindo Pharma317.24B
Fortis Healthcare77.86B
Revenue Rankings

Laurus Labs News

More News